Annual Current Assets
$219.33 M
-$101.48 M-31.63%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total current assets is currently $219.33 million, with the most recent change of -$101.48 million (-31.63%) on 31 December 2023. During the last 3 years, it has risen by +$60.09 million (+37.73%). CPRX annual current assets is now -31.63% below its all-time high of $320.81 million, reached on 31 December 2022.CPRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$539.00 M
+$64.57 M+13.61%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total current assets is currently $539.00 million, with the most recent change of +$64.57 million (+13.61%) on 30 September 2024. Over the past year, it has increased by +$346.98 million (+180.70%). CPRX quarterly current assets is now at all-time high.CPRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.6% | +180.7% |
| 3 y3 years | +37.7% | +179.6% |
| 5 y5 years | +297.4% | +495.1% |
CPRX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.6% | +37.7% | at high | +180.7% |
| 5 y | 5 years | -31.6% | +297.4% | at high | +495.1% |
| alltime | all time | -31.6% | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $539.00 M(+13.6%) |
| June 2024 | - | $474.43 M(+17.3%) |
| Mar 2024 | - | $404.60 M(+84.5%) |
| Dec 2023 | $250.78 M(+357.4%) | $219.33 M(+14.2%) |
| Sept 2023 | - | $192.02 M(-20.3%) |
| June 2023 | - | $240.97 M(+21.1%) |
| Mar 2023 | - | $198.91 M(-38.0%) |
| Dec 2022 | $54.82 M(+98.0%) | $320.81 M(+16.1%) |
| Sept 2022 | - | $276.31 M(+13.9%) |
| June 2022 | - | $242.56 M(+9.7%) |
| Mar 2022 | - | $221.19 M(+5.3%) |
| Dec 2021 | $27.68 M(-16.4%) | $210.11 M(+9.0%) |
| Sept 2021 | - | $192.79 M(+9.4%) |
| June 2021 | - | $176.31 M(+9.1%) |
| Mar 2021 | - | $161.53 M(+1.4%) |
| Dec 2020 | $33.11 M(+3169.8%) | $159.24 M(+11.1%) |
| Sept 2020 | - | $143.34 M(+9.3%) |
| June 2020 | - | $131.16 M(+12.2%) |
| Mar 2020 | - | $116.94 M(+5.0%) |
| Dec 2019 | $1.01 M(-80.8%) | $111.36 M(+22.9%) |
| Sept 2019 | - | $90.58 M(+25.7%) |
| June 2019 | - | $72.06 M(+31.3%) |
| Mar 2019 | - | $54.86 M(-0.6%) |
| Dec 2018 | $5.26 M(+2527.4%) | $55.19 M(-11.7%) |
| Sept 2018 | - | $62.48 M(-9.6%) |
| June 2018 | - | $69.09 M(-12.5%) |
| Mar 2018 | - | $78.94 M(-7.3%) |
| Dec 2017 | $200.30 K(-20.9%) | $85.19 M(+147.5%) |
| Sept 2017 | - | $34.42 M(-3.7%) |
| June 2017 | - | $35.75 M(-4.5%) |
| Mar 2017 | - | $37.46 M(-9.6%) |
| Dec 2016 | $253.10 K(+26.3%) | $41.45 M(-8.0%) |
| Sept 2016 | - | $45.06 M(-7.4%) |
| June 2016 | - | $48.67 M(-9.0%) |
| Mar 2016 | - | $53.48 M(-10.7%) |
| Dec 2015 | $200.40 K | $59.90 M(-6.9%) |
| Sept 2015 | - | $64.36 M(-5.7%) |
| June 2015 | - | $68.26 M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $75.97 M(+73.3%) |
| Dec 2014 | $80.30 K(+62.2%) | $43.83 M(-4.2%) |
| Sept 2014 | - | $45.76 M(-0.2%) |
| June 2014 | - | $45.86 M(+106.9%) |
| Mar 2014 | - | $22.17 M(-12.4%) |
| Dec 2013 | $49.50 K(-20.9%) | $25.32 M(-11.6%) |
| Sept 2013 | - | $28.64 M(+129.4%) |
| June 2013 | - | $12.48 M(-13.3%) |
| Mar 2013 | - | $14.40 M(-13.9%) |
| Dec 2012 | $62.60 K(+196.7%) | $16.73 M(+38.4%) |
| Sept 2012 | - | $12.09 M(+57.3%) |
| June 2012 | - | $7.68 M(+54.7%) |
| Mar 2012 | - | $4.97 M(-20.3%) |
| Dec 2011 | $21.10 K(-62.4%) | $6.23 M(+45.9%) |
| Sept 2011 | - | $4.27 M(-23.4%) |
| June 2011 | - | $5.57 M(-21.5%) |
| Mar 2011 | - | $7.10 M(+22.9%) |
| Dec 2010 | $56.10 K(-29.0%) | $5.78 M(-9.1%) |
| Sept 2010 | - | $6.36 M(+8.7%) |
| June 2010 | - | $5.85 M(-16.1%) |
| Mar 2010 | - | $6.96 M(-11.7%) |
| Dec 2009 | $79.00 K(-32.9%) | $7.89 M(+57.9%) |
| Sept 2009 | - | $4.99 M(-21.8%) |
| June 2009 | - | $6.39 M(-30.1%) |
| Mar 2009 | - | $9.15 M(-23.2%) |
| Dec 2008 | $117.80 K(-20.5%) | $11.92 M(-21.7%) |
| Sept 2008 | - | $15.22 M(+13.6%) |
| June 2008 | - | $13.40 M(-12.7%) |
| Mar 2008 | - | $15.34 M(-7.2%) |
| Dec 2007 | $148.20 K(+367.5%) | $16.53 M(-5.2%) |
| Sept 2007 | - | $17.45 M(-4.0%) |
| June 2007 | - | $18.18 M(-6.0%) |
| Mar 2007 | - | $19.34 M(-6.1%) |
| Dec 2006 | $31.70 K(+77.1%) | $20.59 M(+584.7%) |
| Sept 2006 | - | $3.01 M(+820.0%) |
| June 2006 | - | $326.80 K(-57.6%) |
| Dec 2005 | $17.90 K(+1093.3%) | $771.60 K(+319.6%) |
| Dec 2004 | $1500.00 | $183.90 K |
FAQ
- What is Catalyst Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual current assets year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly current assets year-on-year change?
What is Catalyst Pharmaceuticals annual total current assets?
The current annual current assets of CPRX is $219.33 M
What is the all time high annual current assets for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total current assets is $320.81 M
What is Catalyst Pharmaceuticals annual current assets year-on-year change?
Over the past year, CPRX annual total current assets has changed by -$101.48 M (-31.63%)
What is Catalyst Pharmaceuticals quarterly total current assets?
The current quarterly current assets of CPRX is $539.00 M
What is the all time high quarterly current assets for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total current assets is $539.00 M
What is Catalyst Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, CPRX quarterly total current assets has changed by +$346.98 M (+180.70%)